As FDA uncovers more on heparin, lawmakers say culprits pose...

As FDA uncovers more on heparin, lawmakers say culprits pose current threat
Thursday, February 24th, 2011

According to FDANews, Al-Hakim told the audience ?FDA has also moved into inspecting more of the ?crude? phase of production in China,? something he indicated is a daunting undertaking. Sending one inspector for one week to countries such as China or India costs $20,000 to $25,000.? And at current rates of inspection, some Chinese and foreign plants producing materials for drugs in the U.S. may never be inspected, according to a Pew Prescription Project fact sheet on the safety of the U.S. drug supply.

http://postscript.communitycatalyst.org/?p=2234